{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T20:05:00Z","timestamp":1777752300061,"version":"3.51.4"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T00:00:00Z","timestamp":1748390400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Medical Research Union Fund for High-quality health development of Guizhou Province","award":["2024GZYXKYJJXM0027"],"award-info":[{"award-number":["2024GZYXKYJJXM0027"]}]},{"name":"Innovation and Entrepreneurship Funding Project of Guizhou Province for overseas Talents","award":["2022 10"],"award-info":[{"award-number":["2022 10"]}]},{"DOI":"10.13039\/501100010265","name":"Guizhou Medical University","doi-asserted-by":"publisher","award":["[2024]004"],"award-info":[{"award-number":["[2024]004"]}],"id":[{"id":"10.13039\/501100010265","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Guiyang Science and Technology Plan","award":["[2021] 43-26"],"award-info":[{"award-number":["[2021] 43-26"]}]},{"name":"Guiyang Science and Technology Plan","award":["[2022] 4\\u20137"],"award-info":[{"award-number":["[2022] 4\\u20137"]}]},{"name":"Guizhou Provincial Health Commission Science and Technology Fund Project","award":["gzwkj2024-131"],"award-info":[{"award-number":["gzwkj2024-131"]}]},{"DOI":"10.13039\/501100004001","name":"Guizhou Provincial Science and Technology Department","doi-asserted-by":"publisher","award":["ZK2023366"],"award-info":[{"award-number":["ZK2023366"]}],"id":[{"id":"10.13039\/501100004001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82060033"],"award-info":[{"award-number":["82060033"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81760025"],"award-info":[{"award-number":["81760025"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U23A20498"],"award-info":[{"award-number":["U23A20498"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Key Laboratory Construction Project of Guizhou Medical University"},{"name":"Project of Scientific and Technological Innovation Talent Team in Guizhou Province","award":["CXTD[2021]002"],"award-info":[{"award-number":["CXTD[2021]002"]}]},{"name":"Basic Research Program Project of Guizhou Provincial Department of Science and Technology"},{"DOI":"10.13039\/100017957","name":"Health Commission of Guizhou Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017957","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.bioorg.2025.108612","type":"journal-article","created":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T10:49:15Z","timestamp":1748083755000},"page":"108612","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["A natural flavagline derivative A2073 inhibits the proliferation of erythroleukemia cells by targeting the MAPK, PI3K, NF-\u03baB, and cell cycle pathways"],"prefix":"10.1016","volume":"163","author":[{"given":"Man","family":"Zhou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun-Mao","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-Xu","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei-Ting","family":"Long","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-Ting","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fen-Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun-Xia","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng-Jun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-Xiang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xi-Jun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan-Mei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Yan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2025.108612_bb0005","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1159\/000447076","article-title":"Leukemia","volume":"43","author":"Juliusson","year":"2016","journal-title":"Prog. Tumor Res."},{"issue":"3","key":"10.1016\/j.bioorg.2025.108612_bb0010","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"2","key":"10.1016\/j.bioorg.2025.108612_bb0015","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.blre.2017.09.002","article-title":"Erythroleukemia-historical perspectives and recent advances in diagnosis and management","volume":"32","author":"Boddu","year":"2018","journal-title":"Blood Rev."},{"issue":"4","key":"10.1016\/j.bioorg.2025.108612_bb0020","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1038\/leu.2015.198","article-title":"Molecular characterization of acute erythroid leukemia (M6-AML) using targeted next-generation sequencing","volume":"30","author":"Cervera","year":"2016","journal-title":"Leukemia"},{"issue":"12","key":"10.1016\/j.bioorg.2025.108612_bb0025","doi-asserted-by":"crossref","first-page":"3598","DOI":"10.1002\/ccr3.3316","article-title":"Pure erythroid leukemia","volume":"8","author":"Forest","year":"2020","journal-title":"Clinical Case Rep."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108612_bb0035","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1186\/s12885-023-11060-5","article-title":"Influencing factors of anthracycline-induced subclinical cardiotoxicity in acute leukemia patients","volume":"23","author":"Zhou","year":"2023","journal-title":"BMC Cancer"},{"issue":"18","key":"10.1016\/j.bioorg.2025.108612_bb0040","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1182\/blood.2023019804","article-title":"How I treat long-term survivors of childhood acute leukemia","volume":"143","author":"Saultier","year":"2024","journal-title":"Blood"},{"issue":"11.5","key":"10.1016\/j.bioorg.2025.108612_bb0045","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.6004\/jnccn.2019.5031","article-title":"Therapeutic advances in first-line Management of Acute Myeloid Leukemia","volume":"17","author":"Pollyea","year":"2019","journal-title":"J. Nat. Comprehensive Cancer Netw.\u202f: JNCCN"},{"issue":"12","key":"10.1016\/j.bioorg.2025.108612_bb0050","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1007\/s11864-022-01032-5","article-title":"Central nervous system prophylaxis and treatment in acute Leukemias","volume":"23","author":"Wu","year":"2022","journal-title":"Curr. Treat. Options in Oncol."},{"issue":"11","key":"10.1016\/j.bioorg.2025.108612_bb0055","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1080\/03007995.2019.1631149","article-title":"Side effects from acute myeloid leukemia treatment: results from a national survey","volume":"35","author":"Crossnohere","year":"2019","journal-title":"Curr. Med. Res. Opin."},{"issue":"2","key":"10.1016\/j.bioorg.2025.108612_bb0060","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s10787-024-01596-8","article-title":"The multifaceted anticancer potential of luteolin: involvement of NF-\u03baB, AMPK\/mTOR, PI3K\/Akt, MAPK, and Wnt\/\u03b2-catenin pathways","volume":"33","author":"Singh","year":"2025","journal-title":"Inflammopharmacology"},{"issue":"1","key":"10.1016\/j.bioorg.2025.108612_bb0065","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s12029-024-01160-1","article-title":"PI3K\/AKT\/mTOR targeting in colorectal Cancer radiotherapy: a systematic review","volume":"56","author":"Mousavikia","year":"2025","journal-title":"J. Gastrointest. Cancer"},{"issue":"11","key":"10.1016\/j.bioorg.2025.108612_bb0070","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1038\/s41417-024-00811-6","article-title":"NF-\u03baB role on tumor proliferation, migration, invasion and immune escape","volume":"31","author":"Khan","year":"2024","journal-title":"Cancer Gene Ther."},{"issue":"22","key":"10.1016\/j.bioorg.2025.108612_bb0075","doi-asserted-by":"crossref","first-page":"10064","DOI":"10.1021\/jm301201z","article-title":"Flavaglines as potent anticancer and cytoprotective agents","volume":"55","author":"Ribeiro","year":"2012","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108612_bb0080","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-35908-0","article-title":"Sensitization of renal carcinoma cells to TRAIL-induced apoptosis by rocaglamide and analogs","volume":"8","author":"Nalli","year":"2018","journal-title":"Sci. Rep."},{"issue":"33","key":"10.1016\/j.bioorg.2025.108612_bb0085","doi-asserted-by":"crossref","first-page":"4778","DOI":"10.1038\/onc.2017.93","volume":"36","author":"Targeting prohibitins with chemical ligands inhibits KRAS-mediated lung tumours [published correction appears in Oncogene. 2017 Aug 28;:]","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.bioorg.2025.108612_bb0090","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1476-4598-13-38","article-title":"Targeting the prohibitin scaffold-CRAF kinase interaction in RAS-ERK-driven pancreatic ductal adenocarcinoma","volume":"13","author":"Luan","year":"2014","journal-title":"Mol. Cancer"},{"issue":"7","key":"10.1016\/j.bioorg.2025.108612_bb0095","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1158\/2159-8290.CD-14-1040","article-title":"Targeting translation initiation bypasses signaling crosstalk mechanisms that maintain high MYC levels in colorectal Cancer","volume":"5","author":"Wiegering","year":"2015","journal-title":"Cancer Discov."},{"issue":"9","key":"10.1016\/j.bioorg.2025.108612_bb0100","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1093\/neuonc\/now032","article-title":"Components of the eIF4F complex are potential therapeutic targets for malignant peripheral nerve sheath tumors and vestibular schwannomas","volume":"18","author":"Oblinger","year":"2016","journal-title":"Neuro-Oncology"},{"issue":"10","key":"10.1016\/j.bioorg.2025.108612_bb0105","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1038\/leu.2014.93","article-title":"Flavaglines target primitive leukemia cells and enhance anti-leukemia drug activity","volume":"28","author":"Callahan","year":"2014","journal-title":"Leukemia"},{"issue":"9","key":"10.1016\/j.bioorg.2025.108612_bb0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0076136","article-title":"Therapeutic potential of the translation inhibitor silvestrol in hepatocellular cancer","volume":"8","author":"Kogure","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.bioorg.2025.108612_bb0115","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.canlet.2010.07.015","article-title":"Targeting apoptosis pathways in cancer by Chinese medicine","volume":"332","author":"Li-Weber","year":"2013","journal-title":"Cancer Lett."},{"issue":"6","key":"10.1016\/j.bioorg.2025.108612_bb0120","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1002\/ijc.20033","article-title":"Flavaglines: a group of efficient growth inhibitors block cell cycle progression and induce apoptosis in colorectal cancer cells","volume":"109","author":"Hausott","year":"2004","journal-title":"Int. J. Cancer"},{"issue":"3","key":"10.1016\/j.bioorg.2025.108612_bb0125","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s11101-021-09761-5","article-title":"Comparative phytochemistry of flavaglines (=rocaglamides), a group of highly bioactive flavolignans from Aglaia species (Meliaceae)","volume":"21","author":"Greger","year":"2022","journal-title":"Phytochem. Rev.: Proc. Phytochem. Soc. Europe"},{"issue":"5","key":"10.1016\/j.bioorg.2025.108612_bb0130","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1124\/mol.104.008177","article-title":"A synthetic derivative of the natural product rocaglaol is a potent inhibitor of cytokine-mediated signaling and shows neuroprotective activity in vitro and in animal models of Parkinson's disease and traumatic brain injury","volume":"67","author":"Fahrig","year":"2005","journal-title":"Mol. Pharmacol."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108612_bb0135","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2013.528","article-title":"The traditional Chinese medical compound Rocaglamide protects nonmalignant primary cells from DNA damage-induced toxicity by inhibition of p53 expression","volume":"5","author":"Becker","year":"2014","journal-title":"Cell Death Dis."},{"issue":"2","key":"10.1016\/j.bioorg.2025.108612_bb0140","doi-asserted-by":"crossref","first-page":"585","DOI":"10.7150\/ijbs.65019","article-title":"Rocaglamide promotes the infiltration and antitumor immunity of NK cells by activating cGAS-STING signaling in non-small cell lung cancer","volume":"18","author":"Yan","year":"2022","journal-title":"Int. J. Biol. Sci."},{"issue":"340","key":"10.1016\/j.bioorg.2025.108612_bb0145","article-title":"Hara: a potent anti-tumor herbal remedy - botany, phytochemistry, and clinical applications and insights","volume":"31","author":"Gao","year":"2025","journal-title":"J. Ethnopharmacol."},{"issue":"Pt 4","key":"10.1016\/j.bioorg.2025.108612_bb0150","article-title":"Polysaccharides from Lonicera japonica Thunb.: extraction, purification, structural features and biological activities-a review","volume":"281","author":"Gao","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bioorg.2025.108612_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.156436","article-title":"Unveiling polysaccharides of Houttuynia cordata Thunb.: extraction, purification, structure, bioactivities, and structure-activity relationships","volume":"138","author":"Gao","year":"2025","journal-title":"Phytomedicine"},{"issue":"4","key":"10.1016\/j.bioorg.2025.108612_bb0160","doi-asserted-by":"crossref","first-page":"3948","DOI":"10.1021\/acs.jmedchem.4c01257","article-title":"Artificial intelligence in natural product drug discovery: current applications and future perspectives","volume":"68","author":"Gangwal","year":"2025","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108612_bb0165","doi-asserted-by":"crossref","first-page":"53","DOI":"10.31557\/APJCP.2021.22.1.53","article-title":"Cytotoxic and apoptotic activity of Aglaforbesin derivative isolated from Aglaia loheri Merr. On HCT116 human colorectal Cancer cells","volume":"22","author":"Abalos","year":"2021","journal-title":"Asian Pac. J. Cancer Prev."},{"issue":"3","key":"10.1016\/j.bioorg.2025.108612_bb0170","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1021\/acs.jnatprod.9b01285","article-title":"Natural products as sources of new drugs over the nearly four decades from 01\/1981 to 09\/2019","volume":"83","author":"Newman","year":"2020","journal-title":"J. Nat. Prod."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108612_bb0175","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/s13046-021-01923-9","article-title":"Correction to: Flavagline analog FL3 induces cell cycle arrest in urothelial carcinoma cell of the bladder by inhibiting the Akt\/PHB interaction to activate the GADD45\u03b1 pathway","volume":"40","author":"Yuan","year":"2021","journal-title":"J. Exp. & Clin. Cancer Res.: CR"},{"key":"10.1016\/j.bioorg.2025.108612_bb0180","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.2147\/DDDT.S357891","article-title":"The Flavagline compound 1-(2-(dimethylamino)acetyl)-Rocaglaol induces apoptosis in K562 cells by regulating the PI3K\/Akt\/mTOR, JAK2\/STAT3, and MAPK pathways","volume":"16","author":"Yang","year":"2022","journal-title":"Drug Des. Devel. Ther."},{"issue":"13","key":"10.1016\/j.bioorg.2025.108612_bb0185","article-title":"Jiyuan oridonin a induces differentiation of acute myeloid leukemia cells including leukemic stem-like cells","volume":"5","author":"Li","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108612_bb0190","first-page":"26","article-title":"Differentiation therapy of myeloid leukemia: four decades of development","volume":"106","author":"Madan","year":"2021","journal-title":"Haematologica"},{"issue":"15","key":"10.1016\/j.bioorg.2025.108612_bb0195","article-title":"All-trans retinoic acid in hematologic disorders: not just acute promyelocytic leukemia","volume":"4","author":"Chen","year":"2024","journal-title":"Front. Pharmacol."},{"issue":"7","key":"10.1016\/j.bioorg.2025.108612_bb0200","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.3390\/cancers17071141","article-title":"Recent developments in differentiation therapy of acute myeloid leukemia","volume":"17","author":"Testa","year":"2025","journal-title":"Cancers"},{"key":"10.1016\/j.bioorg.2025.108612_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216980","article-title":"Neratinib impairs function of m6A recognition on AML1-ETO pre-mRNA and induces differentiation of t (8;21) AML cells by targeting HNRNPA3","volume":"594","author":"Liu","year":"2024","journal-title":"Cancer Lett."},{"issue":"2","key":"10.1016\/j.bioorg.2025.108612_bb0210","first-page":"109","article-title":"Crosstalk between the Smad and the mitogen-activated protein kinase pathways is essential for erythroid differentiation of Erythroleukemia cells induced by TGF-\u03b2, Activin, hydroxyurea and butyrate","volume":"1","author":"Akel","year":"2013","journal-title":"J. Leukemia (Los Angeles, Calif.)"},{"issue":"5","key":"10.1016\/j.bioorg.2025.108612_bb0215","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1111\/bjh.18735","article-title":"Abemaciclib drives the therapeutic differentiation of acute myeloid leukaemia stem cells","volume":"201","author":"Xie","year":"2023","journal-title":"Br. J. Haematol."},{"issue":"12","key":"10.1016\/j.bioorg.2025.108612_bb0220","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1182\/blood.2024024008","article-title":"How I treat acute myeloid leukemia with differentiation therapy","volume":"145","author":"Issa","year":"2025","journal-title":"Blood"},{"key":"10.1016\/j.bioorg.2025.108612_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2021.107927","article-title":"The role of CD71+ erythroid cells in the regulation of the immune response","volume":"228","author":"Grzywa","year":"2021","journal-title":"Pharmacol. Ther."},{"issue":"13","key":"10.1016\/j.bioorg.2025.108612_bb0230","doi-asserted-by":"crossref","first-page":"6634","DOI":"10.1093\/nar\/gkad468","article-title":"Multidimensional profiling reveals GATA1-modulated stage-specific chromatin states and functional associations during human erythropoiesis","volume":"51","author":"Li","year":"2023","journal-title":"Nucleic Acids Res."},{"issue":"25","key":"10.1016\/j.bioorg.2025.108612_bb0235","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1182\/blood.2019003867","article-title":"GPS2 promotes erythroid differentiation by control of the stability of EKLF protein","volume":"135","author":"Ma","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.bioorg.2025.108612_bb0240","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.exphem.2020.06.004","article-title":"The transcription factor NFE2 enhances expression of the hematopoietic master regulators SCL\/TAL1 and GATA2","volume":"87","author":"Siegwart","year":"2020","journal-title":"Exp. Hematol."},{"issue":"11","key":"10.1016\/j.bioorg.2025.108612_bb0245","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/gt.2017.88","article-title":"SHIP1, but not an AML-derived SHIP1 mutant, suppresses myeloid leukemia growth in a xenotransplantation mouse model","volume":"24","author":"T\u00e4ger","year":"2017","journal-title":"Gene Ther."},{"issue":"4","key":"10.1016\/j.bioorg.2025.108612_bb0250","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1007\/s00432-022-04135-6","article-title":"Cyclins and cyclin-dependent kinases: from biology to tumorigenesis and therapeutic opportunities","volume":"149","author":"Zabihi","year":"2023","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108612_bb0255","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41580-021-00404-3","article-title":"Cell cycle control in cancer","volume":"23","author":"Matthews","year":"2022","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"11","key":"10.1016\/j.bioorg.2025.108612_bb0260","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202400769R","article-title":"Cell cycle machinery in oncology: a comprehensive review of therapeutic targets","volume":"38","author":"Cavalu","year":"2024","journal-title":"FASEB J."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108612_bb0265","doi-asserted-by":"crossref","first-page":"4281","DOI":"10.1038\/s41467-025-59700-7","article-title":"Phosphate-binding pocket on cyclin B governs CDK substrate phosphorylation and mitotic timing","volume":"16","author":"Ng","year":"2025","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.bioorg.2025.108612_bb0270","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.tcb.2024.04.003","article-title":"The centrosome: a critical hub for cell cycle regulation","volume":"34","author":"Yoshino","year":"2024","journal-title":"Trends Cell Biol."},{"issue":"20","key":"10.1016\/j.bioorg.2025.108612_bb0275","doi-asserted-by":"crossref","first-page":"12701","DOI":"10.1093\/nar\/gkae824","article-title":"Protein-RNA interactions mediated by silvestrol-insight into a unique molecular clamp","volume":"52","author":"Naineni","year":"2024","journal-title":"Nucleic Acids Res."},{"issue":"4","key":"10.1016\/j.bioorg.2025.108612_bb0280","doi-asserted-by":"crossref","first-page":"160","DOI":"10.31083\/j.fbl2904160","article-title":"Activation of the MEK\/ERK pathway mediates the inhibitory effects of Silvestrol on nasopharyngeal carcinoma cells via RAP1A, HK2, and GADD45A","volume":"29","author":"Yu","year":"2024","journal-title":"Front. Biosci. (Landmark Ed)"},{"issue":"6","key":"10.1016\/j.bioorg.2025.108612_bb0285","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.3892\/etm.2016.3201","article-title":"Inhibition of nasopharyngeal carcinoma cell proliferation and synergism of cisplatin with silvestrol and episilvestrol isolated from Aglaia stellatopilosa","volume":"11","author":"Daker","year":"2016","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.bioorg.2025.108612_bb0290","article-title":"The eIF4A inhibitor Silvestrol blocks the growth of human glioblastoma cells by inhibiting AKT\/mTOR and ERK1\/2 signaling pathway","volume":"2022","author":"Zhang","year":"2022","journal-title":"J. Oncol."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108612_bb0295","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s12943-023-01827-6","article-title":"PI3K\/AKT\/mTOR signaling transduction pathway and targeted therapies in cancer","volume":"22","author":"Glaviano","year":"2023","journal-title":"Mol. Cancer"},{"issue":"3","key":"10.1016\/j.bioorg.2025.108612_bb0300","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.3390\/ijms24032652","article-title":"The role of PI3K\/AKT\/mTOR signaling in hepatocellular carcinoma metabolism","volume":"24","author":"Tian","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2025.108612_bb0305","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.semcancer.2019.12.008","article-title":"Natural products targeting the PI3K-Akt-mTOR signaling pathway in cancer: a novel therapeutic strategy","volume":"80","author":"Tewari","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.bioorg.2025.108612_bb0310","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.2147\/OTT.S189032","article-title":"Oral PI3K-\u03b4,\u03b3 Inhibitor for the Management of People with Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma: A Narrative Review on Duvelisib","volume":"14","author":"Shah","year":"2021","journal-title":"Onco Targets Ther"},{"issue":"8","key":"10.1016\/j.bioorg.2025.108612_bb0315","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1002\/ijc.29013","article-title":"Molecular mechanisms and anti-cancer aspects of the medicinal phytochemicals rocaglamides (=flavaglines)","volume":"137","author":"Li-Weber","year":"2015","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.bioorg.2025.108612_bb0320","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1039\/D0NP00024H","article-title":"Rocaglamide and silvestrol: a long story from anti-tumor to anti-coronavirus compounds","volume":"38","author":"Schulz","year":"2021","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.bioorg.2025.108612_bb0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119499","article-title":"Interplay between MAPK\/ERK signaling pathway and MicroRNAs: a crucial mechanism regulating cancer cell metabolism and tumor progression","volume":"278","author":"Asl","year":"2021","journal-title":"Life Sci."},{"issue":"3","key":"10.1016\/j.bioorg.2025.108612_bb0330","first-page":"1997","article-title":"ERK\/MAPK signalling pathway and tumorigenesis","volume":"19","author":"Guo","year":"2020","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.bioorg.2025.108612_bb0335","article-title":"Recent advances in signaling pathways and kinase inhibitors for leukemia chemotherapy","author":"Liu","year":"2024","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108612_bb0340","article-title":"Characterization of MEK1\/2 degraders uncovers a kinase-independent role for MEK1\/2 in the stabilization and maturation of CRAF","author":"Wasserman","year":"2025","journal-title":"BioRxiv: Preprint Server Biol."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108612_bb0345","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a033746","article-title":"Ras-mediated activation of the Raf family kinases","volume":"9","author":"Terrell","year":"2019","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"5","key":"10.1016\/j.bioorg.2025.108612_bb0350","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/nri.2017.142","article-title":"NF-\u03baB, inflammation, immunity and cancer: coming of age","volume":"18","author":"Taniguchi","year":"2018","journal-title":"Nat. Rev. Immunol."},{"issue":"11","key":"10.1016\/j.bioorg.2025.108612_bb0355","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.3324\/haematol.2017.173419","article-title":"Targeting metabolism and survival in chronic lymphocytic leukemia and Richter syndrome cells by a novel NF-\u03baB inhibitor","volume":"102","author":"Vaisitti","year":"2017","journal-title":"Haematologica"},{"issue":"3","key":"10.1016\/j.bioorg.2025.108612_bb0360","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.gendis.2020.06.005","article-title":"The nuclear factor kappa B (NF-kB) signaling in cancer development and immune diseases","volume":"8","author":"Zinatizadeh","year":"2020","journal-title":"Genes & Diseases"},{"issue":"1","key":"10.1016\/j.bioorg.2025.108612_bb0365","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s12964-023-01433-5","article-title":"Interplay between proteasome inhibitors and NF-\u03baB pathway in leukemia and lymphoma: a comprehensive review on challenges ahead of proteasome inhibitors","volume":"22","author":"Pakjoo","year":"2024","journal-title":"Cell Comm. Signal.\u202f: CCS"},{"issue":"1","key":"10.1016\/j.bioorg.2025.108612_bb0370","doi-asserted-by":"crossref","first-page":"3901","DOI":"10.1038\/s41467-024-48288-z","article-title":"CLK2 mediates I\u03baB\u03b1-independent early termination of NF-\u03baB activation by inducing cytoplasmic redistribution and degradation","volume":"15","author":"Li","year":"2024","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.bioorg.2025.108612_bb0375","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.7150\/ijbs.70567","article-title":"Alizarin, a nature compound, inhibits the growth of pancreatic cancer cells by abrogating NF-\u03baB activation","volume":"18","author":"Xu","year":"2022","journal-title":"Int. J. Biol. Sci."},{"issue":"11","key":"10.1016\/j.bioorg.2025.108612_bb0380","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1002\/cac2.12096","article-title":"The ongoing trends of patient-derived xenograft models in oncology","volume":"40","author":"Zhuo","year":"2020","journal-title":"Cancer Communications (London, England)"},{"key":"10.1016\/j.bioorg.2025.108612_bb0385","doi-asserted-by":"crossref","DOI":"10.1089\/zeb.2020.1857","article-title":"Technical updates to the comet assay in vivo for assessing DNA damage in zebrafish embryos from fresh and frozen cell suspensions","author":"Martins","year":"2020","journal-title":"Zebrafish"},{"issue":"1","key":"10.1016\/j.bioorg.2025.108612_bb0390","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/s41698-023-00386-9","article-title":"Refined high-content imaging-based phenotypic drug screening in zebrafish xenografts","volume":"7","author":"Sturtzel","year":"2023","journal-title":"NPJ Precision Oncol."},{"issue":"10","key":"10.1016\/j.bioorg.2025.108612_bb0395","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.3390\/nu15102369","article-title":"Testing the anticancer effect of Matcha using zebrafish as an animal model","volume":"15","author":"Sokary","year":"2023","journal-title":"Nutrients"},{"issue":"11","key":"10.1016\/j.bioorg.2025.108612_bb0400","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2118220119","article-title":"Proteome-wide cellular thermal shift assay reveals unexpected cross-talk between brassinosteroid and auxin signaling","volume":"119","author":"Lu","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825004924?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825004924?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T11:59:31Z","timestamp":1777463971000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206825004924"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":79,"alternative-id":["S0045206825004924"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108612","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A natural flavagline derivative A2073 inhibits the proliferation of erythroleukemia cells by targeting the MAPK, PI3K, NF-\u03baB, and cell cycle pathways","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108612","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"108612"}}